Santiago Aguiar Espellet Soares

Santiago Aguiar Espellet Soares

Auto-generated profile, based on publicly available information

Santiago Aguiar Espellet Soares

Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Brazil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2022 in Parasitology Research
Verified
Journal Article
Closed access
PDF file
MTMirian Vieira Teixeira
Mirian Vieira Teixeira
SSSantiago Aguiar Espellet Soares
Santiago Aguiar Espellet Soares
VSVagniton Amélio Souza
Vagniton Amélio Souza
AMAndré Murilo de Souza Marques
André Murilo de Souza Marques
CSCelia Maria De Almeida Soares
Celia Maria De Almeida Soares
MOMilton Adriano Pelli de Oliveira
Milton Adriano Pelli de Oliveira

28 March 2025 in World Journal of Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
AMAndré Murilo de Souza Marques
André Murilo de Souza Marques
SSSantiago Aguiar Espellet Soares
Santiago Aguiar Espellet Soares
JNJosé Rodrigues do Carmo Neto
José Rodrigues do Carmo Neto
CGClayson Moura Gomes
Clayson Moura Gomes
MVMarina Clare Vinaud
Marina Clare Vinaud
MOMilton Adriano Pelli de Oliveira
Milton Adriano Pelli de Oliveira

17 August 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
MCMatheus Batista Carneiro
Matheus Batista Carneiro
SSSantiago Aguiar E. Soares
Santiago Aguiar E. Soares
CTChris Tiessen
Chris Tiessen
CGCamila Gaio
Camila Gaio
BPBen Perks
Ben Perks
NPNathan C Peters
Nathan C Peters
Protective immunity against many infectious diseases develops following primary infection, called infection induced immunity (III), and provides a blueprint for vaccination. However, many vaccination strategies have failed. In the parasitic Leishmania major model of self-healing cutaneous disease, control of secondary challenge infection relies on pre-existing T helper (Th)1-dependent activation of skin-infiltrating monocytes for elimination of intracellular parasites. To better understand immune-evasion of pre-existing Th1 immunity by pathogens, we investigated the pathogen-niche established following non-healing challenge infection with the L. amazonensis parasite in a setting of pre-existing III. Following secondary challenge, pre-existing Th1 III initially controlled infection but ultimately failed. Loss of protection was not overtly STAT6- or IL-10-mediated. Rather, monocyte-lineage tracing revealed inflammatory monocyte-derived PD-L1+PD-L2+ macrophages provide an intracellular pathogen-niche and facilitate evasion of pre-existing Th1 immunity. Anti-PD-1 immune checkpoint blockade enhanced uninfected, but not infected, monocyte-derived cell activation and depletion of monocyte-derived precursors improved parasite control. These observations suggest that evasion of pre-existing Th1 immunity in this setting is not due to a failure of the Th1 response, but rather due to infected-cell intrinsic defects in activation.